/
/
/

Astal Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Mar 2025
₹101 Cr₹134 Cr₹23 Cr
₹14 L₹10 L₹4 L
₹101 Cr₹134 Cr₹24 Cr
₹90 Cr₹125 Cr₹19 Cr
₹12 Cr₹10 Cr₹4 Cr
₹1 Cr₹1 Cr₹27 L
₹10 Cr₹8 Cr₹4 Cr
₹9 Cr₹8 Cr₹3 Cr

Share Price Live Stats

Open (₹)80.35
Volume (₹)12,106.00
High (₹)80.35
Upper Circuit95.32
Low (₹)77.11
Lower Circuit63.56
Prev Close79.44
52W High (₹)103.20
Price78.00
52W Low (₹)60.45

Share Market Cap & Key Ratios Overview

M.Cap (₹)347.94 Cr
Div. Yield (%)0.00
PE Ratio35.74
Debt to Equity0.41
Price to Book2.32
Book Value32.81
EPS (TTM)2.22
Face Value10.00
ROE (%)32.12

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
ASTALLTD-XNSE
LTP
1W Low
1W High
Market cap (₹)
1901.6-18.5 (-0.96%)
1900.10
1964.85
4,56,833Cr
9186.2-82.8 (-0.89%)
9051.85
9296
2,45,426Cr
4860.1-174.9 (-3.47%)
4858.35
5049
1,87,320Cr
1131.9-55.1 (-4.64%)
1126
1191.45
1,13,217Cr
1380-38 (-2.68%)
1377
1426.20
1,12,212Cr
1852.1-83.2 (-4.30%)
1812
1947.90
1,01,155Cr
2122.65-52.35 (-2.41%)
2117.80
2209
97,626Cr
2336-51.4 (-2.15%)
2323.15
2407.40
96,859Cr
1160.9-16.9 (-1.43%)
1155
1179.90
96,406Cr
1656.8+6.8 (0.41%)
1623.05
1706.70
93,614Cr
78-0.74 (-0.94%)
77
81
348Cr

Key Highlights of Astal Laboratories Ltd’s P&L

In 2025-03-31, Astal Laboratories Ltd reported total revenue of ₹64.23Cr, compared with ₹23.65Cr in 2024-03-31, reflecting Astal Laboratories Ltd turnover.

Depreciation was ₹22.31Lakh and finance costs were ₹70.07Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹11.98Cr in 2025-03-31 as compared to ₹1.09Cr in 2024-03-31.

Net Profit (PAT) was ₹8.93Cr in 2025-03-31 compared with ₹78.47Lakh in 2024-03-31.

Earnings per share (EPS) were ₹9.08 in 2025-03-31, compared with ₹0.80 in 2024-03-31.